EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe
Royal Philips announced the launch of EXIT-CVD, a five-year EU-co-funded research consortium it co-leads with University Medical Center Groningen, targeting cardiovascular disease across 42 partners in 17 countries. The program carries a EUR 27.6 million budget and will run 22 clinical studies enrolling more than 14,000 patients, with first enrollments beginning this month.
Key figures
- Num studies
- 22
- Num partners
- 42
- Num patients
- 14,000+
- Num countries
- 17
- Duration years
- 5
- Project budget
- EUR 27.6 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.